Divi's Laboratories Ltd. News and Updates

Name: Latest research reports of Divi's Laboratories Ltd. authored by KRChoksey and published by - Trendlyne research reports.
Item: Divi's Laboratories Ltd.
Rating: 4
Author: KRChoksey

Keep track of all breaking news on Divi's Laboratories Ltd. from all sources in a single place.

Load latest

Divi's Laboratories Ltd.

11 Nov 2024

6012.50

-3.27%

Multiple growth levers to drive Custom Synthesis segment

Accumulate: Divi's Laboratories Ltd.

Target

KRChoksey

Divis Lab revenue beat our estimates significantly due to strong growth in the Custom Synthesis segment. EBITDA beat our estimate due to lower-than-expected other expenses and employee expenses.

Divi's Laboratories Ltd. is trading above all available SMAs

Divi's Laboratories Ltd.

10 Nov 2024

6012.50

-3.27%

Divi's Labs (SELL): Healthy Q2; rich valuations

Sell: Divi's Laboratories Ltd.

Target

BOB Capital Markets Ltd.

DIVI reported healthy 2QFY25 earnings which was a beat on our estimates. Exports contributed 87% of sales and the US 71%

Divi's Laboratories Ltd. is trading above all available SMAs

Divi's Laboratories Ltd.

09 Nov 2024

6012.50

-3.27%

Divi's Laboratories Ltd. Results Earnings Call for Q2FY25

Conference Call with Divi's Laboratories Ltd. Management and Analysts on Q2FY25 Performance and Outlook. Listen to the full earnings transcript.

Divi's Laboratories Ltd.

07 Nov 2024

6012.50

-3.27%

Divis Labs Q2 Preview: Net profit may jump 36%, revenue by 15 YoY%

Business Standard

Brokerages expect Divis Labs to report a robust quarter on a year-on-year basis and sequentially

Divi's Laboratories .. has an average target of 5832.12 from 9 brokers.

Divi's Laboratories Ltd.

07 Aug 2024

6012.50

-3.27%

Ramp up in custom synthesis and new generic APIs to drive margins

Hold: Divi's Laboratories Ltd.

Target

KRChoksey

DIVISLAB continues to post results below estimates due to continued weakness in generic pricing. We hence cut down our EPS estimates by 3% each for FY25E/FY26E.

Divi's Laboratories Ltd. has gained 57.65% in the last 1 Year

Divi's Laboratories Ltd.

05 Aug 2024

6012.50

-3.27%

to see Rapid results content

Divi's Laboratories Ltd.

05 Aug 2024

6012.50

-3.27%

Earnings growth priced-in Divi's Labs stock, niche biz to expand: Analysts

Business Standard

Shares of Divis Laboratories fell 2.41 to Rs 4870 per share on the BSE in Monday's intraday deals. This came despite the company delivering a 21 percent year-on-year (YoY) rise in net profit

Divi's Laboratories Ltd. is trading above all available SMAs

Divi's Laboratories Ltd.

05 Aug 2024

6012.50

-3.27%